Insights in Gynecologic Oncology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Current Trends Gynecol Oncol ; 7:125,
  • DOI: 10.4172/ctgo.1000125

Designated treatment for gynecologic Cancer: Toward the period of accuracy medication

Stephanie Ricci*
School of Biosciences, Faculty of Medical and Health Sciences, Taylor's University, 47500 Subang Jaya, Selangor Darul Ehsan, Malaysia
*Corresponding Author : Stephanie Ricci, School of Biosciences, Faculty of Medical and Health Sciences, Taylor's University, 47500 Subang Jaya, Selangor Darul Ehsan, Malaysia, Email: Stephanie_Ma@gmail.com

Received Date: Aug 02, 2022 / Published Date: Aug 30, 2022

Citation: Ricci S (2022) Designated treatment for gynecologic Cancer: Toward the period of accuracy medication. Current Trends Gynecol Oncol, 7: 125. Doi: 10.4172/ctgo.1000125

Copyright: © 2022 Ricci S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top